VERRICA PHARMACEUTICALS INC (VRCA)
US92511W1080 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 69.55M | 34.27M | 15.75M | 10.69M | 9.24M | |||
| Marketable Securities | N/A | 0.00 | 54.60M | 54.78M | 52.78M | |||
| Receivables | 4.42M | 490.00K | N/A | N/A | N/A | |||
| Inventories | 1.02M | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 2.54M | 4.36M | 3.97M | 2.18M | 2.97M | |||
| Total Current Assets | 77.53M | 39.12M | 74.33M | 67.65M | 64.98M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.62M | 5.33M | 5.50M | 4.94M | 2.20M | |||
| Other Non-Current Assets | 452.00K | 280.00K | 300.00K | 1.57M | 1.24M | |||
| Total Non-Current Assets | 4.07M | 5.60M | 5.80M | 6.50M | 3.44M | |||
| TOTAL ASSETS | 81.60M | 44.72M | 80.13M | 74.15M | 68.42M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 376.00K | 0.00 | 41.70M | 35.32M | N/A | |||
| Accrued Expenses | 14.18M | 2.95M | 3.51M | 3.31M | 2.17M | |||
| Accounts Payable | 2.46M | 510.00K | 850.00K | 350.00K | 1.19M | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 500.00K | N/A | |||
| Total Current Liabilities | 17.02M | 3.46M | 46.06M | 39.48M | 3.35M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 43.90M | 0.00 | 20.00K | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 910.00K | 1.23M | 1.45M | 1.69M | 60.00K | |||
| Total Non-Current Liabilities | 44.81M | 1.23M | 1.46M | 1.69M | 60.00K | |||
| TOTAL LIABILITIES | 61.83M | 4.69M | 47.52M | 41.17M | 3.41M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -230.45M | -163.45M | -138.97M | -103.89M | -61.19M | |||
| Additional Paid In Capital | 250.21M | 203.48M | 171.60M | 136.87M | 126.59M | |||
| Common Shares | 4.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | 0.00 | N/A | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | -30.00K | 0.00 | -390.00K | |||
| Shares Outstanding | 42.41M | 41.09M | 27.52M | 25.44M | 25.81M | |||
| Tangible Book Value per Share | 0.47 | 0.97 | 1.19 | 1.30 | 2.52 | |||
| Total Shareholders' Equity | 19.76M | 40.03M | 32.61M | 32.99M | 65.02M | |||
| TOTAL LIABILITIES AND EQUITY | 81.60M | 44.72M | 80.13M | 74.15M | 68.42M | |||
| Statistics | ||||||||
| Debt/Equity | 2.22 | N/A | 0.00 | N/A | N/A | |||
| Current Ratio | 4.55 | 11.31 | 1.61 | 1.71 | 19.40 | |||
| Return On Assets (ROA) | -82.10% | -54.76% | -43.78% | -57.57% | -41.23% | |||
| Return On Equity (ROE) | -338.99% | -61.18% | -107.57% | -129.40% | -43.39% | |||
All data in USD